Emerson’s Michalle Adkins and Ron Rossbach will host a webinar on reducing time to market for new therapies—a key opportunity for pharmaceutical and biopharmaceutical manufacturers. This webinar will take place on August 13 at 15:00 CET – Europe / 09:00 EDT.
At the Biomanufacturing World Summit, Emerson’s Ron Rossbach presented on using digitalization and data integration to help drive operational efficiency. A key enabling technology for these performance gains is in real-time adaptive scheduling. This technology combines finite scheduling with dynamic updates from existing shop-floor execution systems to optimize operations. In 2018 Emerson acquired BioG, the leading provider of adaptive scheduling software, which is now being adopted across the industry.
At the recent 2019 China International Biopharma4.0 Summit, Emerson's Ron Rossbach presented Biopharma 4.0—Integrated Software Enabling Digital Capabilities. I'll highlight some of Ron's key points. He opened describing some of the main challenges biopharmaceutical...
As automation technologies continue to incorporate commercial off the shelf technologies and cybersecurity concerns grow, the need for manufacturers' Information Technology (IT), Operational Technology (OT) and Quality teams to collaborate grows. In a PharmTech...
In a U.S. Food and Drug Administration's FDA Voice blog post, FDA Budget Matters: Investing in Advanced Domestic Manufacturing, FDA Commissioner Dr. Scott Gottlieb opened noting: Advanced manufacturing, which includes various technologies, such as continuous...
We invite you to follow us on Facebook, LinkedIn, Twitter and YouTube to stay up to date on the latest news, events and innovations that will help you face and solve your toughest challenges.
Just post a link to the entry and send us a quick note so we can share your work. Thank you very much.
Our Global Community
Emerson Exchange 365
This blog features expert perspectives from Emerson's automation professionals on industry trends, technologies, and best practices. The information shared here is intended to inform and educate our global community of users and partners.